Is a big pharma LBO on the horizon?

With AstraZeneca's CFO Jon Symonds leaving for Goldman Sachs, I wonder if it's a sign we'll see someone have a go at taking a big pharma company private. I wrote about the concept here.

Previous
Previous

Health Wonk Review

Next
Next

This is a good start